ALRGN Bio's Unattributed Round

ALRGN Bio raised a round of funding on December 20, 2016.

Alrgn Bio combines its patented food grade enzymatic process with current food industry processing equipment to inactivate peanut allergens. The resulting reduced allergen peanuts have the potential t…

Articles about ALRGN Bio's Unattributed Round: